Corbion reports strong 2025 results with 26.7% organic growth in Adjusted EBITDA

NETHERLANDS – Corbion, a global leader in sustainable food ingredients and biochemicals, announced exceptional full-year 2025 financial results driven by solid operational performance and improved cash generation, and announced a special dividend to return value to shareholders

The company reported organic growth in Adjusted EBITDA of 26.7%, reaching €204.3 million (US$237.26M), alongside a staggering 63.3% increase in earnings per share (EPS) and free cash flow (FCF) of €90.8 million (US$105.45M).

These figures reflect Corbion’s strategic focus on high-margin solutions in nutrition, preservation, and functional ingredients for food, feed, and pharma sectors.

Organic sales grew by 2.2% to €1,267.4 million (US$1,471.97M), driven by 3.4% volume/mix expansion despite pricing pressures and currency headwinds.

Adjusted EBITDA margin expanded to 16.1%, up 250 basis points year-over-year, fueled by operational efficiencies and portfolio optimization in key segments like Health & Nutrition, which posted high single-digit volume growth and a robust Q4 surge of over 40%.

Operating profit soared 66.1% organically to €116.5 million (US$135.31M), with cash flow from operations at €160.9 million (US$186.88M) supporting the strong FCF generation.

CEO Olivier Rigaud hailed the results as a testament to team execution, exceeding targets for sales, EBITDA, and cash flow in a year marked by supply chain resilience.

Olivier Rigaud, CEO, stated: “I am pleased to announce a strong set of results and recognize the excellent delivery of our teams. In 2025, we met our ambitious growth targets for sales and organic Adjusted EBITDA, and again exceeded our Free Cash Flow goal.”

In celebration of this outperformance, Corbion proposed a total dividend of €1.00 (US $1.16) per share, including a standard €0.64 (US$0.74) payout and a special dividend of €0.36 (US$0.42), signaling confidence in future cash generation.

Q4 alone delivered +5.4% organic sales growth and +39.9% Adjusted EBITDA growth, underscoring momentum into 2026.

Looking ahead, Corbion signaled that it will continue to prioritize operational excellence, innovation in bio‑based ingredients, and selective capital deployment to support long‑term value creation.

The company said it will update the market on any changes to guidance or strategic initiatives at upcoming investor events and in its regular reporting cadence.

The results highlight Corbion’s agility in navigating raw material volatility, particularly in fish oil and aquaculture, while advancing sustainable practices, such as bio-based preservatives that align with global clean-label trends.

“We would really also like to add this technology of botanical extraction to our portfolio because we speak about rosemary as a big one, but you see also you have a lot of polyphenols coming from a grape or green tea that are a strong antioxidant or ascorbic acid that is also a vitamin, natural vitamin C coming from acerola berry,” Olivier Rigaud said.

Corbion’s outlook for fiscal 2026 includes organic sales growth between 3% to 6% and adjusted EBITDA margin of about 17%.

Sign up to HERE receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.